Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Bauer, KA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bauer, KA
      Fondaparinux sodium: A selective inhibitor of factor Xa

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    2. Bauer, KA
      Home-based telemedicine: A survey of ethical issues

      CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS
    3. Bauer, KA
      Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: Don't bother

      THROMBOSIS AND HAEMOSTASIS
    4. Eriksson, BI; Bauer, KA; Lassen, MR; Turpie, AGG
      Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Bauer, KA; Eriksson, BI; Lassen, MR; Turpie, AGG
      Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

      NEW ENGLAND JOURNAL OF MEDICINE
    6. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
      Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

      CIRCULATION
    7. Ardissino, D; Merlini, PA; Bauer, KA; Bramucci, E; Ferrario, M; Coppola, R; Fetiveau, R; Lucreziotti, S; Rosenberg, RD; Mannucci, PM
      Thrombogenic potential of human coronary atherosclerotic plaques

      BLOOD
    8. Peyvandi, F; Carew, JA; Perry, DJ; Hunault, M; Khanduri, U; Perkins, SJ; Mannucci, PM; Bauer, KA
      Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene

      BLOOD
    9. Bauer, KA
      The thrombophilias: Well-defined risk factors with uncertain therapeutic implications

      ANNALS OF INTERNAL MEDICINE
    10. Merlini, PA; Ardissino, D; Rosenberg, RD; Colombi, E; Agricola, P; Oltrona, L; Ottani, F; Galvani, M; Bauer, KA; Bottasso, B; Bertocchi, F; Mannucci, PM
      In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. Minnema, MC; Peters, RJG; de Winter, R; Lubbers, YPT; Barzegar, S; Bauer, KA; Rosenberg, RD; Hack, CE; ten Cate, H
      Activation of clotting factors XI and IX in patients with acute myocardialinfarction

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    12. Bauer, KA
      Venous thromboembolism in malignancy

      JOURNAL OF CLINICAL ONCOLOGY
    13. Bauer, KA; Humphries, S; Smillie, B; Li, L; Cooper, JA; Barzegar, S; Rosenberg, RD; Miller, GJ
      Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations

      THROMBOSIS AND HAEMOSTASIS
    14. Bovill, EG; Hasstedt, SJ; Callas, PW; Valliere, JE; Scott, BT; Bauer, KA; Long, GL
      The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred

      THROMBOSIS AND HAEMOSTASIS
    15. Bauer, KA
      The ethical and social dimensions of home-based telemedicine

      CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
    16. Hunault, M; Bauer, KA
      Recombinant factor VIIa for the treatment of congenital factor VII deficiency

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    17. Cooper, JA; Miller, GJ; Bauer, KA; Morrissey, JH; Meade, TW; Howarth, DJ; Barzegar, S; Mitchell, JP; Rosenberg, RD
      Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

      CIRCULATION
    18. Carew, JA; Pollak, ES; Lapaciuk, S; Bauer, KA
      Anew mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency

      BLOOD
    19. Bauer, KA
      Activation markers of coagulation

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    20. Wulf, GM; Van Deerlin, VMD; Leonard, DGB; Bauer, KA
      Thrombosis in a patient with combined homozygosity for the factor V Leidenmutation and a mutation in the 3 '-untranslated region of the prothrombin gene

      BLOOD COAGULATION & FIBRINOLYSIS
    21. Xu, X; Bauer, KA; Griffin, JH
      Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms

      THROMBOSIS RESEARCH
    22. Hunault, M; Marsh-Scott, C; Jou, C; Marshall, R; Scheffel, C; Fiore, LD; Bauer, KA; Mitchell, MJ
      Automated detection of the factor V Leiden mutation using the LCx microparticle enzyme immunoassay

      CLINICAL CHEMISTRY
    23. Hunault, M; Arbini, AA; Carew, JA; Bauer, KA
      Mechanism underlying factor VII deficiency in Jewish populations with the Ala(244)Val mutation

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Hunault, M; Bauer, KA
      Homozygous Q100R mutations in the second EGF-like domain of factor VII - Response

      BLOOD
    25. Hunault, M; Arbini, AA; Carew, JA; Peyvandi, F; Bauer, KA
      Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII

      BLOOD
    26. MERLINI PA; ARDISSINO D; BAUER KA; OLTRONA L; GALVANI M; OTTANI F; MANNUCCI PM; ROSENBERG RD
      TRANSIENT DECREASE OF THROMBIN GENERATION DURING HIRUDIN TREATMENT INPATIENTS WITH ACUTE CORONARY SYNDROMES

      Journal of the American College of Cardiology
    27. MILLER GJ; BAUER KA; COOPER JA; ROSENBERG RD
      ACTIVATION OF THE COAGULANT PATHWAY IN CIGARETTE SMOKERS

      Thrombosis and haemostasis
    28. OLTRONA L; MERLINI PA; NIGUARDA O; ARDISSINO D; BAUER KA; GALVANI M; OTTANI F; AGRICOLA P; PEZZANO A; MANNUCCI PM; ROSENBERG RD
      PARTIAL REACTIVATION OF HEMOSTATIC MECHANISM AFTER HIRUDIN DISCONTINUATION IN PATIENTS WITH ACUTE CORONARY SYNDROMES

      Circulation
    29. BAUER KA
      MANAGEMENT OF INHERITED THROMBOPHILIA

      British Journal of Haematology
    30. CAREW JA; POLLAK ES; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO A MUTATION DISRUPTING AN SP1 BINDING-SITE IN THE FACTOR-VII PROMOTER

      Blood
    31. BAUER KA
      HOW TO DETECT ACTIVATED COAGULATION

      Fibrinolysis & proteolysis
    32. MERLINI PA; ARDISSINO D; BAUER KA; OLTRONA L; PEZZANO A; BOTTASSO B; ROSENBERG RD; MANNUCCI PM
      PERSISTENT THROMBIN GENERATION DURING HEPARIN-THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROMES

      Arteriosclerosis, thrombosis, and vascular biology
    33. HUNAULT M; ARBINI AA; LOPACIUK S; CAREW JA; BAUER KA
      THE ARG(353)GLN POLYMORPHISM REDUCES THE LEVEL OF COAGULATION-FACTOR-VII - IN-VIVO AND IN-VITRO STUDIES

      Arteriosclerosis, thrombosis, and vascular biology
    34. BAUER KA
      ACTIVATION OF THE FACTOR-VII TISSUE FACTOR PATHWAY

      Thrombosis and haemostasis
    35. LANE DA; MANNUCCI PM; BAUER KA; BERTINA RM; BOCHKOV NP; BOULYJENKOV V; CHANDY M; DAHLBACK B; GINTER EK; MILETICH JP; ROSENDAAL FR; SELIGSOHN U
      INHERITED THROMBOPHILIA .2. (VOL 76, PG 824, 1996)

      Thrombosis and haemostasis
    36. HUNAULT M; ARBINI AA; LOPACLUK S; BAUER KA
      THE ARG353GLN (R353Q) POLYMORPHISM REDUCES THE LEVEL OF COAGULATION-FACTOR-VII (FVII) - IN-VIVO AND IN-VITRO STUDIES

      Thrombosis and haemostasis
    37. MILLER GJ; BAUER KA; COOPER JA; ROSENBERG RD
      ACTIVATION OF THE COAGULATION PATHWAY IN CIGARETTE SMOKERS

      Thrombosis and haemostasis
    38. HUNAULT M; MARSHSCOTT C; JOU C; MARSHALL R; SCHEFFEL C; FIORE LD; BAUER KA; MITCHELL MJ
      AUTOMATED DETECTION OF THE FACTOR-V-LEIDEN MUTATION USING MICROPARTICLE ENZYME-IMMUNOASSAY (MEIA)

      Blood
    39. HUNAULT M; ARBINI AA; CAREW JA; BAUER KA
      CELLULAR MECHANISM OF THE FACTOR-VII (FVII)-ALA(244)VAL MUTATION IN JEWISH POPULATIONS

      Blood
    40. ARBINI AA; POLLAK ES; BAYLERAN JK; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO A MUTATION DISRUPTING A HEPATOCYTE NUCLEAR FACTOR-4 BINDING-SITE IN THE FACTOR-VII PROMOTER

      Blood
    41. SILVEIRA A; KARPE F; JOHNSSON H; BAUER KA; HAMSTEN A
      IN-VIVO DEMONSTRATION IN HUMANS THAT LARGE POSTPRANDIAL TRIGLYCERIDE-RICH LIPOPROTEINS ACTIVATE COAGULATION-FACTOR-VII THROUGH THE INTRINSIC COAGULATION PATHWAY

      Arteriosclerosis, thrombosis, and vascular biology
    42. LANE DA; MANNUCCI PM; BAUER KA; BERTINA RM; BOCHKOV NP; BOULYJENKOV V; CHANDY M; DAHLBACK B; GINTER EK; MILETICH JP; ROSENDAAL FR; SELIGSOHN U
      INHERITED THROMBOPHILIA .2.

      Thrombosis and haemostasis
    43. LANE DA; MANNUCCI PM; BAUER KA; BERTINA RM; BOCHKOV NP; BOULYJENKOV V; CHANDY M; DAHLBACK B; GINTER EK; MILETICH JP; ROSENDAAL FR; SELIGSOHN U
      INHERITED THROMBOPHILIA .1.

      Thrombosis and haemostasis
    44. MILLER GJ; BAUER KA; BARZEGAR S; COOPER JA; ROSENBERG RD
      INCREASED ACTIVATION OF THE HEMOSTATIC SYSTEM IN MEN AT HIGH-RISK OF FATAL CORONARY HEART-DISEASE

      Thrombosis and haemostasis
    45. VANBOVEN HH; REITSMA PH; ROSENDAAL FR; BAYSTON TA; CHOWDHURY V; BAUER KA; SCHARRER I; CONARD J; LANE DA
      FACTOR-V LEIDEN (FV R506Q) IN FAMILIES WITH INHERITED ANTITHROMBIN DEFICIENCY

      Thrombosis and haemostasis
    46. TENCATE H; BIEMOND BJ; LEVI M; WUILLEMIN WA; BAUER KA; BARZEGAR S; BULLER HR; HACK CE; TENCATE JW; ROSENBERG RD
      FACTOR XIA INDUCED ACTIVATION OF THE INTRINSIC CASCADE IN-VIVO

      Thrombosis and haemostasis
    47. BAUER KA; EICHINGER S; MANNUCCI PM; ROSENBERG RD
      DETERMINANTS OF COAGULATION ACTIVATION IN HUMANS

      Haemostasis
    48. BAUER KA
      TREATMENT OF FACTOR-VII DEFICIENCY WITH RECOMBINANT FACTOR VIIA

      Haemostasis
    49. BAUER KA; GRAEMECOOK FM; KAUFMAN JA; TERUYA J
      AN 18-YEAR-OLD WOMAN WITH HEPATOMEGALY AND ASCITES - BUDD-CHIARI SYNDROME - PROTEIN-C DEFICIENCY

      The New England journal of medicine
    50. HUNAULT M; ARBINI AA; LOPACIUK S; BAUER KA
      THE ARG353GLN (R353Q) POLYMORPHISM REDUCES THE LEVEL OF COAGULATION-FACTOR-VII (FVII) - IN-VIVO AND IN-VITRO STUDIES

      Blood
    51. POLLAK ES; CAREW JA; ARBINI AA; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO MUTATIONS DISRUPTING HNF-4 AND SP1 BINDING-SITES IN THE FACTOR-VII PROMOTER

      Blood
    52. MERLINI PA; BAUER KA; OLTRONA L; ARDISSINO D; SPINOLA A; CATTANEO M; BROCCOLINO M; MANNUCCI PM; ROSENBERG RD
      THROMBIN GENERATION AND ACTIVITY DURING THROMBOLYSIS AND CONCOMITANT HEPARIN-THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Journal of the American College of Cardiology
    53. ARBINI AA; MANNUCCI PM; BAUER KA
      LOW-PREVALENCE OF THE FACTOR-V LEIDEN MUTATION AMONG SEVERE HEMOPHILIACS WITH A MILDER BLEEDING DIATHESIS

      Thrombosis and haemostasis
    54. BAUER KA
      MANAGEMENT OF PATIENTS WITH HEREDITARY DEFECTS PREDISPOSING TO THROMBOSIS INCLUDING PREGNANT-WOMEN

      Thrombosis and haemostasis
    55. MILLER GJ; BAUER KA; BARZEGAR S; FOLEY AJ; MITCHELL JP; COOPER JA; ROSENBERG RD
      THE EFFECTS OF QUALITY AND TIMING OF VENIPUNCTURE ON MARKERS OF BLOOD-COAGULATION IN HEALTHY MIDDLE-AGED MEN

      Thrombosis and haemostasis
    56. BAUER KA; GRIFFIN JH
      FACTOR-V LEIDEN AND THROMBOPHILIA - REPLY

      The New England journal of medicine
    57. MERLINI PA; ARDISSINO D; BAUER KA; OLTRONA L; BROCCOLINO M; MANNUCCI PM; ROSENBERG RD
      PERSISTENT THROMBIN GENERATION DURING HEPARIN TREATMENT IN PATIENTS WITH ACUTE CORONARY SYNDROMES

      Circulation
    58. MERLINI PA; ARDISSINO D; BAUER KA; OLTRONA L; SPINOLA A; DIOTALLEVI P; ROSENBERG RD; MANNUCCI PM
      ACTIVATION OF THE HEMOSTATIC MECHANISM DURING THROMBOLYSIS IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS

      Blood
    59. EICHINGER S; MANNUCCI PM; TRADATI F; ARBINI AA; ROSENBERG RD; BAUER KA
      DETERMINANTS OF PLASMA FACTOR VIIA LEVELS IN HUMANS

      Blood
    60. ARBINI AA; MANNUCCI PM; BAUER KA
      A THR(359)MET MUTATION IN FACTOR-VII OF A PATIENT WITH A HEREDITARY-DEFICIENCY CAUSES DEFECTIVE SECRETION OF THE MOLECULE

      Blood
    61. MARI D; MANNUCCI PM; COPPOLA R; BOTTASSO B; BAUER KA; ROSENBERG RD
      HYPERCOAGULABILITY IN CENTENARIANS - THE PARADOX OF SUCCESSFUL AGING

      Blood
    62. SCHMAIER AH; DAHL LD; HASAN AAK; CINES DB; BAUER KA; VANNOSTRAND WE
      FACTOR IXA INHIBITION BY PROTEASE NEXIN-2 AMYLOID BETA-PROTEIN PRECURSOR ON PHOSPHOLIPID-VESICLES AND CELL-MEMBRANES

      Biochemistry
    63. BAUER KA; ROSENBERG RD
      ACTIVATION MARKERS OF COAGULATION

      Bailliere's clinical haematology
    64. SANTAGOSTINO E; MANNUCCI PM; GRINGERI A; TAGARIELLO G; BAUDO F; BAUER KA; ROSENBERG RD
      MARKERS OF HYPERCOAGULABILITY IN PATIENTS WITH HEMOPHILIA-B GIVEN REPEATED, LARGE DOSES OF FACTOR-IX CONCENTRATES DURING AND AFTER SURGERY

      Thrombosis and haemostasis
    65. GREENGARD JS; EICHINGER S; GRIFFIN JH; BAUER KA
      VARIABILITY OF THROMBOSIS AMONG HOMOZYGOUS SIBLINGS WITH RESISTANCE TO ACTIVATED PROTEIN-C DUE TO AN ARG-]GLN MUTATION IN THE GENE FOR FACTOR-V

      The New England journal of medicine
    66. BAUER KA
      HYPERCOAGULABILITY - A NEW COFACTOR IN THE PROTEIN-C ANTICOAGULANT PATHWAY

      The New England journal of medicine
    67. LEVI M; TENCATE H; BAUER KA; VANDERPOLL T; EDGINGTON TS; BULLER HR; VANDEVENTER SJH; HACK CE; TENCATE JW; ROSENBERG RD
      INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF COAGULATION AND FIBRINOLYSIS BY PENTOXIFYLLINE OR BY A MONOCLONAL ANTITISSUE FACTOR ANTIBODY IN CHIMPANZEES

      The Journal of clinical investigation
    68. MERLINI PA; BAUER KA; OLTRONA L; ARDISSINO D; CATTANEO M; BELLI C; MANNUCCI PM; ROSENBERG RD
      PERSISTENT ACTIVATION OF COAGULATION MECHANISM IN UNSTABLE ANGINA ANDMYOCARDIAL-INFARCTION

      Circulation
    69. ARBINI AA; BODKIN D; LOPACIUK S; BAUER KA
      MOLECULAR ANALYSIS OF POLISH PATIENTS WITH FACTOR-VII DEFICIENCY

      Blood
    70. MANNUCCI PM; BAUER KA; SANTAGOSTINO E; FAIONI E; BARZEGAR S; COPPOLA R; ROSENBERG RD
      ACTIVATION OF THE COAGULATION CASCADE AFTER INFUSION OF A FACTOR-XI CONCENTRATE IN CONGENITALLY DEFICIENT PATIENTS

      Blood
    71. MANNUCCI PM; MARI D; COPPOLA R; BAUER KA; ROSENBERG RD; BONOMI AB
      HYPERCOAGULABILITY IN CENTENARIANS - THE PARADOX OF SUCCESSFUL AGING

      Blood
    72. ARBINI AA; BAUER KA; BIANCHI A
      REDUCED PLASMA FACTOR-VII COAGULANT ACTIVITY DUE TO THE ARG353GLN POLYMORPHISM IN THE FACTOR-VII GENE RESULTS FROM DEFECTIVE SECRETION

      Blood
    73. EICHINGER S; MANNUCCI PM; TRADATI F; ARBINI AA; ROSENBERG RD; BAUER KA
      DETERMINANTS OF PLASMA FACTOR-VIIA LEVELS IN HUMANS

      Blood
    74. CHOWDHURY V; OLDS RJ; LANE DA; PABINGER I; MACHIN SJ; RYAN K; BAUER KA; BHAVNANI M; ABILDGAARD U; FINAZZI G; CONARD J; HORELLOU MH; CASTAMAN G; MANNUCCI PM; THEIN SL
      IDENTIFICATION OF 9 NOVEL MUTATIONS IN TYPE-I ANTITHROMBIN DEFICIENCYBY HETERODUPLEX SCREENING

      Thrombosis and haemostasis
    75. MERLINI PA; BAUER KA; OLTRONA L; SPINOLA A; ARDISSINO D; CATTANEO M; BOTTASSO B; LOMBARDO M; MANNUCCI PM; ROSENBERG RD
      ACTIVATION OF THE HEMOSTATIC MECHANISM AND DEGRADATION OF ANTITHROMBIN-III DURING THROMBOLYSIS

      Thrombosis and haemostasis
    76. MERLINI PA; BAUER KA; MANNUCCI PM; OLTRONA L; ARDISSINO D; LOMBARDO M; CATTANEO M; BELLI C; ROSENBERG RD
      PERSISTENT ACTIVATION OF THE COAGULATION MECHANISM IN UNSTABLE ANGINAAND MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    77. VANDERPOLL T; LEVI M; TENCATE H; BAUER KA; HACK CE; VANDEVENTER SJH; BULLER HR; ROSENBERG RD; AARDEN LA; TENCATE JW
      ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES INHIBIT ENDOTOXIN-INDUCED ACTIVATION OF COAGULATION IN CHIMPANZEES

      Thrombosis and haemostasis
    78. BAUER KA; ARBINI AA; LOPACIUK S
      CHARACTERIZATION OF POLISH FAMILIES WITH FACTOR-VII (FVII) DEFICIENCY

      Thrombosis and haemostasis
    79. KISTLER JP; SINGER DE; MILLENSON MM; BAUER KA; GRESS DR; BARZEGAR S; HUGHES RA; SHEEHAN MA; MARAVENTANO SW; OERTEL LB; ROSNER B; ROSENBERG RD
      EFFECT OF LOW-INTENSITY WARFARIN ANTICOAGULATION ON LEVEL OF ACTIVITYOF THE HEMOSTATIC SYSTEM IN PATIENTS WITH ATRIAL-FIBRILLATION

      Stroke
    80. TENCATE H; BAUER KA; LEVI M; EDGINGTON TS; SUBLETT RD; BARZEGAR S; KASS BL; ROSENBERG RD
      THE ACTIVATION OF FACTOR-X AND PROTHROMBIN BY RECOMBINANT FACTOR VIIAIN-VIVO IS MEDIATED BY TISSUE FACTOR

      The Journal of clinical investigation
    81. ROSENBERG RD; BAUER KA
      PROTHROMBIN ACTIVATION FRAGMENT ASSAY

      Clinical chemistry
    82. CHOWDHURY V; OLDS RJ; LANE DA; CONARD J; PABINGER I; RYAN K; BAUER KA; BHAVNANI M; ABILDGAARD U; FINAZZI G; CASTAMAN G; MANNUCCI PM; THEIN SL
      IDENTIFICATION OF 9 NOVEL MUTATIONS IN TYPE-I ANTITHROMBIN DEFICIENCYBY HETERODUPLEX SCREENING

      British Journal of Haematology
    83. CONARD J; BAUER KA; GRUBER A; GRIFFIN JH; SCHWARZ HP; HORELLOU MH; SAMAMA MM; ROSENBERG RD
      NORMALIZATION OF MARKERS OF COAGULATION ACTIVATION WITH A PURIFIED PROTEIN-C CONCENTRATE IN ADULTS WITH HOMOZYGOUS PROTEIN-C DEFICIENCY

      Blood
    84. ARBINI AA; BODKIN D; LOPACIUK S; BAUER KA
      THE ARG353 TO GLN POLYMORPHISM IS A MAJOR DETERMINANT OF THE PHENOTYPE IN PATIENTS WITH FACTOR-VII (FVII) DEFICIENCY

      Blood
    85. GRINGERI A; SANTAGOSTINO E; BOTTASSO B; BARZEGAR S; BAUER KA; ROSENBERG RD; MANNUCCI PM
      NO ACTIVATION OF THE COAGULATION CASCADE AFTER MULTIPLE DOSES OF HIGH-PURITY FACTOR-IX (FIX) CONCENTRATES IN HEMOPHILIACS UNDERGOING SURGERY

      Blood
    86. SCHRAMM W; SPANNAGL M; BAUER KA; ROSENBERG RD; BIRKNER B; LINNAU Y; SCHWARZ HP
      TREATMENT OF COUMARIN-INDUCED SKIN NECROSIS WITH A MONOCLONAL-ANTIBODY PURIFIED PROTEIN-C CONCENTRATE

      Archives of dermatology
    87. BAUER KA
      COUMARIN-INDUCED SKIN NECROSIS

      Archives of dermatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 22:08:47